Potential use of fosfomycin-tromethamine for treatment of recurrent Campylobacter species enteritis

Juan Aguilar-Company; Ibai Los-Arcos; Carles Pigrau; Dolors Rodríguez-Pardo; María Nieves Larrosa; Virginia Rodríguez-Garrido; Denisse Sihuay-Diburga; Benito Almirante

doi:10.1128/AAC.00447-16

Potential use of fosfomycin-tromethamine for treatment of recurrent Campylobacter species enteritis

Juan Aguilar-Company, Ibai Los-Arcos, Carles Pigrau, Dolors Rodríguez-Pardo, María Nieves Larrosa, Virginia Rodríguez-Garrido, Denisse Sihuay-Diburga, Benito Almirante

Research output: Contribution to journal › Article › Research › peer-review

11 Citations (Scopus)

Abstract

Copyright © 2016, American Society for Microbiology. All Rights Reserved. We report 2 cases of recurrent Campylobacter coli enteritis caused by macrolide- and fluoroquinolone-resistant strains in 2 patients with hypogammaglobulinemia, successfully treated with a prolonged course of fosfomycin-tromethamine with no side effects. Fosfomycin-tromethamine may be a feasible alternative therapy for recurrent enteritis caused by Campylobacter species resistant to first-line drugs.

Original language	English
Pages (from-to)	4398-4400
Journal	Antimicrobial Agents and Chemotherapy
Volume	60
Issue number	7
DOIs	https://doi.org/10.1128/AAC.00447-16
Publication status	Published - 1 Jul 2016

Access to Document

10.1128/AAC.00447-16

Fingerprint Dive into the research topics of 'Potential use of fosfomycin-tromethamine for treatment of recurrent Campylobacter species enteritis'. Together they form a unique fingerprint.

Cite this

Aguilar-Company, Juan ; Los-Arcos, Ibai ; Pigrau, Carles ; Rodríguez-Pardo, Dolors ; Larrosa, María Nieves ; Rodríguez-Garrido, Virginia ; Sihuay-Diburga, Denisse ; Almirante, Benito. / Potential use of fosfomycin-tromethamine for treatment of recurrent Campylobacter species enteritis. In: Antimicrobial Agents and Chemotherapy. 2016 ; Vol. 60, No. 7. pp. 4398-4400.

@article{6cf6d1b2a3e04807ab367383590433a0,

title = "Potential use of fosfomycin-tromethamine for treatment of recurrent Campylobacter species enteritis",

abstract = "Copyright {\textcopyright} 2016, American Society for Microbiology. All Rights Reserved. We report 2 cases of recurrent Campylobacter coli enteritis caused by macrolide- and fluoroquinolone-resistant strains in 2 patients with hypogammaglobulinemia, successfully treated with a prolonged course of fosfomycin-tromethamine with no side effects. Fosfomycin-tromethamine may be a feasible alternative therapy for recurrent enteritis caused by Campylobacter species resistant to first-line drugs.",

author = "Juan Aguilar-Company and Ibai Los-Arcos and Carles Pigrau and Dolors Rodr{\'i}guez-Pardo and Larrosa, {Mar{\'i}a Nieves} and Virginia Rodr{\'i}guez-Garrido and Denisse Sihuay-Diburga and Benito Almirante",

year = "2016",

month = jul,

day = "1",

doi = "10.1128/AAC.00447-16",

language = "English",

volume = "60",

pages = "4398--4400",

number = "7",

}

Potential use of fosfomycin-tromethamine for treatment of recurrent Campylobacter species enteritis. / Aguilar-Company, Juan; Los-Arcos, Ibai; Pigrau, Carles; Rodríguez-Pardo, Dolors; Larrosa, María Nieves; Rodríguez-Garrido, Virginia; Sihuay-Diburga, Denisse; Almirante, Benito.

In: Antimicrobial Agents and Chemotherapy, Vol. 60, No. 7, 01.07.2016, p. 4398-4400.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - Potential use of fosfomycin-tromethamine for treatment of recurrent Campylobacter species enteritis

AU - Aguilar-Company, Juan

AU - Los-Arcos, Ibai

AU - Pigrau, Carles

AU - Rodríguez-Pardo, Dolors

AU - Larrosa, María Nieves

AU - Rodríguez-Garrido, Virginia

AU - Sihuay-Diburga, Denisse

AU - Almirante, Benito

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Copyright © 2016, American Society for Microbiology. All Rights Reserved. We report 2 cases of recurrent Campylobacter coli enteritis caused by macrolide- and fluoroquinolone-resistant strains in 2 patients with hypogammaglobulinemia, successfully treated with a prolonged course of fosfomycin-tromethamine with no side effects. Fosfomycin-tromethamine may be a feasible alternative therapy for recurrent enteritis caused by Campylobacter species resistant to first-line drugs.

AB - Copyright © 2016, American Society for Microbiology. All Rights Reserved. We report 2 cases of recurrent Campylobacter coli enteritis caused by macrolide- and fluoroquinolone-resistant strains in 2 patients with hypogammaglobulinemia, successfully treated with a prolonged course of fosfomycin-tromethamine with no side effects. Fosfomycin-tromethamine may be a feasible alternative therapy for recurrent enteritis caused by Campylobacter species resistant to first-line drugs.

U2 - 10.1128/AAC.00447-16

DO - 10.1128/AAC.00447-16

M3 - Article

VL - 60

SP - 4398

EP - 4400

IS - 7

ER -